Literature DB >> 10506049

Controversial aspects of thyroid disease.

F W Hanna1, J H Lazarus, M F Scanlon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506049      PMCID: PMC1116724          DOI: 10.1136/bmj.319.7214.894

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  32 in total

1.  Thyroid register audit: a district general hospital experience.

Authors:  S Y Tan; G V Gill; T Hales
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.

Authors:  L J DeGroot; C A Gorman; A Pinchera; L Bartalena; C Marcocci; W M Wiersinga; M F Prummel; L Wartofsky; C ] Marocci C [corrected to Marcocci
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

3.  Effects of restricting levothyroxine dosage strength availability.

Authors:  K B Ain; F Pucino; G Csako; R A Wesley; J A Drass; C Clark; P Ketteridge; K Crawford; S M Banks; T E Dorworth
Journal:  Pharmacotherapy       Date:  1996 Nov-Dec       Impact factor: 4.705

4.  Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy.

Authors:  R A Metcalfe; A P Weetman
Journal:  Clin Endocrinol (Oxf)       Date:  1994-01       Impact factor: 3.478

5.  Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.

Authors:  J V Parle; J A Franklyn; K W Cross; S R Jones; M C Sheppard
Journal:  Br J Gen Pract       Date:  1993-03       Impact factor: 5.386

6.  Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.

Authors:  J Faber; A M Galløe
Journal:  Eur J Endocrinol       Date:  1994-04       Impact factor: 6.664

7.  Thyroxine replacement therapy and circulating lipid concentrations.

Authors:  J A Franklyn; J Daykin; J Betteridge; E A Hughes; R Holder; S R Jones; M C Sheppard
Journal:  Clin Endocrinol (Oxf)       Date:  1993-05       Impact factor: 3.478

8.  Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH.

Authors:  G P Leese; R T Jung; C Guthrie; N Waugh; M C Browning
Journal:  Clin Endocrinol (Oxf)       Date:  1992-12       Impact factor: 3.478

9.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.

Authors:  C T Sawin; A Geller; P A Wolf; A J Belanger; E Baker; P Bacharach; P W Wilson; E J Benjamin; R B D'Agostino
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

10.  Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism.

Authors:  W C Nicholas; R G Fischer; R A Stevenson; J D Bass
Journal:  South Med J       Date:  1995-09       Impact factor: 0.954

View more
  5 in total

Review 1.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

2.  Challenges of treating thyroid disease: the need for a revisit.

Authors:  Biju Jose; A James
Journal:  J R Soc Med       Date:  2007-02       Impact factor: 5.344

Review 3.  Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin.

Authors:  W Stuart A Smellie; Jamie J Coleman
Journal:  BMJ       Date:  2007-02-10

4.  Menorrhagia and hypothyroidism. Evidence supports association between hypothyroidism and menorrhagia.

Authors:  A D Weeks
Journal:  BMJ       Date:  2000-03-04

5.  Pituitary hyperplasia: a complication of the pseudomalabsorption of thyroxine.

Authors:  Mary-Anne Doyle; Heather A Lochnan
Journal:  Int J Gen Med       Date:  2013-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.